DarioHealth Corp. — Form 8-K
Filed July 10, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
DarioHealth filed an 8-K on July 10, 2026, disclosing Item 5.02 events (departure of directors or officers and/or compensatory arrangements). The filing does not contain the substantive text detailing which officers departed, which directors were affected, specific compensation amounts, dates of departure, or replacement appointments. Only the cover page and XBRL metadata are visible in this extract.
Why this rating
Personnel changes are routine for small-cap firms. Without specifics (who left, compensation, replacement), materiality cannot be assessed. At $28M market cap, even leadership departures are not automatically transformational if operations continue.
Extracted items
See more from July 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.